A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
A Phase 3, randomized, active-controlled, study in pediatric subjects. It is designed to
evaluate the safety and anesthetic efficacy of one dose of AG-920 ophthalmic solution
compared to Proparacaine HCl Ophthalmic Solution.